Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  AtriCure Inc.    ATRC

ATRICURE INC.

(ATRC)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/20/2019 05/21/2019 05/22/2019 05/23/2019 05/24/2019 Date
29.41(c) 29.84(c) 29.7(c) 29.31(c) 29.51(c) Last
114 413 207 477 158 279 114 663 49 423 Volume
-0.03% +1.46% -0.47% -1.31% +0.68% Change
More quotes
Financials (USD)
Sales 2019 226 M
EBIT 2019 -24,3 M
Net income 2019 -25,4 M
Finance 2019 38,0 M
Yield 2019 -
Sales 2020 254 M
EBIT 2020 -19,2 M
Net income 2020 -19,9 M
Finance 2020 64,0 M
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020
EV / Sales2019 4,87x
EV / Sales2020 4,23x
Capitalization 1 140 M
More Financials
Company
AtriCure, Inc. is an atrial fibrillation (Afib) solutions company. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. It has various product lines for the ablation... 
More about the company
Surperformance© ratings of AtriCure Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ATRICURE INC.
05/21ATRICURE INC. : (ATRC) CFO Sells $295,500.00 in Stock
AQ
04/26ATRICURE : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
04/25ATRICURE : 1Q Earnings Snapshot
AQ
04/25ATRICURE, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
04/25ATRICURE : Reports First Quarter 2019 Financial Results
BU
04/23ATRICURE : Announces First Patient Enrollment in the DEEP IDE Trial Restart
BU
04/04ATRICURE : to Announce First Quarter 2019 Financial Results
BU
04/01ATRICURE : to Present at the Needham & Company's 18th Annual Healthcare Conferen..
BU
03/01ATRICURE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
02/28ATRICURE, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
More news
Analyst Recommendations on ATRICURE INC.
More recommendations
Sector news : Medical Equipment, Supplies & Distribution - NEC
05/24ZIMMER BIOMET : SEC Issues $4.5 Million Whistleblower Award
DJ
05/24Foreign investors hope India dials back policy shocks after Modi win
RE
05/23GLOBAL MARKETS LIVE : Amazon, LVMH, Sprint, T-Mobile…
05/23MEDTRONIC : Expects Currency Exchange Rates to Weigh on 2020 Sales
DJ
05/23MEDTRONIC : 4Q Profit Falls on Higher Expenses, Restructuring Charge
DJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Chart ATRICURE INC.
Duration : Period :
AtriCure Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ATRICURE INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Average target price 36,7 $
Spread / Average Target 24%
EPS Revisions
Managers
NameTitle
Michael H. Carrel President, Chief Executive Officer & Director
Scott William Drake Chairman
Douglas J. Seith Chief Operating Officer
M. Andrew Wade CFO, Principal Accounting Officer & Senior VP
Vini Doraiswamy SVP-Clinical, Regulatory & Scientific Affairs
Sector and Competitors
1st jan.Capitalization (M$)
ATRICURE INC.-3.56%1 140
MEDTRONIC PLC0.75%124 767
BAXTER INTERNATIONAL INC.14.10%38 314
HOYA CORPORATION20.06%27 047
ALIGN TECHNOLOGY48.72%24 919
ZIMMER BIOMET HOLDINGS10.41%23 453